Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06999265 · ClinicalTrials.gov registry record · NA
Effect of Peripheral Neuromodulation on Vaginal Blood Flow - Study 2
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT06999265: Completed NA study, sponsored by University of Michigan.
NCT06999265 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06999265, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The overall purpose of this research is to improve sexual function in women with sexual dysfunction. The goal of this study is to see if either of two nerve stimulation interventions cause a short-term change in vaginal blood flow. The effect of this intervention will be compared between women who have neurogenic (spinal cord injury) or non-neurogenic dysfunction and healthy women, to reveal mechanisms underlying neural control over vaginal blood flow.
Primary Outcome
VPA will be measured by a vaginal plethysmography transducer that is placed in the vagina to measure changes in blood flow during the full study session. Overall treatment sequence: baseline (nature) video erotic video 1 (no treatment = "control") baseline nature video (treatment on in middle) erotic video 2 (treatment) The average VPA value during the baseline period will be determined. The maximum percent change in VPA during each relevant sequence as compared to the average baseline VPA wi
Interventions
- DEVICE Transcutaneous electrical nerve stimulation - Tibial Nerve
- DEVICE Transcutaneous electrical nerve stimulation - Genital Nerve
- BEHAVIORAL Neutral and Erotic Film Clip Alternation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2024-06-05 |
| Phase | NA |
What the finished NCT06999265 record still lists
NCT06999265 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Transcutaneous electrical nerve stimulation - Tibial Nerve is the first listed.
NCT06999265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06999265 about?
NCT06999265 is a clinical study titled "Effect of Peripheral Neuromodulation on Vaginal Blood Flow - Study 2". The overall purpose of this research is to improve sexual function in women with sexual dysfunction. The goal of this study is to see if either of two nerve stimulation interventions cause a short-term change in vaginal blood flow. The effect of this intervention will be compared between women who h...
What is the current status of trial NCT06999265?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-09-14. Estimated completion is 2024-06-05.
What interventions are being tested in trial NCT06999265?
The interventions under investigation include: Transcutaneous electrical nerve stimulation - Tibial Nerve (DEVICE), Transcutaneous electrical nerve stimulation - Genital Nerve (DEVICE), Neutral and Erotic Film Clip Alternation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06999265?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06999265's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI